Related Experiment Video
Updated: Oct 7, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
SMURF2 phosphorylation at Thr249 modifies glioma stemness and tumorigenicity by regulating TGF-β receptor stability
Manami Hiraiwa1, Kazuya Fukasawa1, Takashi Iezaki2
1Department of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University, Gifu, 501-1196, Japan.
Abstract:
Glioma stem cells (GSCs) contribute to the pathogenesis of glioblastoma, the most malignant form of glioma. The implication and underlying mechanisms of SMAD specific E3 ubiquitin protein ligase 2 (SMURF2) on the GSC phenotypes remain unknown. We previously demonstrated that SMURF2 phosphorylation at Thr249 (SMURF2Thr249) activates its E3 ubiquitin ligase activity. Here, we demonstrate that SMURF2Thr249 phosphorylation plays an essential role in maintaining GSC stemness and tumorigenicity. SMURF2 silencing augmented the self-renewal potential and tumorigenicity of patient-derived GSCs. The SMURF2Thr249 phosphorylation level was low in human glioblastoma pathology specimens. Introduction of the SMURF2T249A mutant resulted in increased stemness and tumorigenicity of GSCs, recapitulating the SMURF2 silencing. Moreover, the inactivation of SMURF2Thr249 phosphorylation increases TGF-β receptor (TGFBR) protein stability. Indeed, TGFBR1 knockdown markedly counteracted the GSC phenotypes by SMURF2T249A mutant. These findings highlight the importance of SMURF2Thr249 phosphorylation in maintaining GSC phenotypes, thereby demonstrating a potential target for GSC-directed therapy.
Insights
SMAD specific E3 ubiquitin protein ligase 2 (SMURF2) phosphorylation at Thr249 is crucial for maintaining glioma stem cell (GSC) stemness and tumorigenicity. Inactivating this phosphorylation promotes GSC phenotypes by increasing TGF-β receptor stability.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Glioma stem cells (GSCs) drive glioblastoma, the deadliest brain tumor.
- The role of SMAD specific E3 ubiquitin protein ligase 2 (SMURF2) in GSCs is unclear.
- SMURF2 phosphorylation at Thr249 (SMURF2^Thr249) activates its E3 ubiquitin ligase activity.
Purpose of the Study:
- To investigate the role of SMURF2^Thr249 phosphorylation in GSC stemness and tumorigenicity.
- To elucidate the underlying mechanisms involving SMURF2 in GSC phenotypes.
Main Methods:
- Studied patient-derived GSCs.
- Utilized SMURF2 silencing and SMURF2^T249A mutant.
- Assessed GSC self-renewal and tumorigenicity.
- Analyzed SMURF2^Thr249 phosphorylation levels in glioblastoma specimens.
- Investigated the effect on TGF-β receptor (TGFBR) stability and function.
Main Results:
- SMURF2^Thr249 phosphorylation is essential for GSC stemness and tumorigenicity.
- SMURF2 silencing increased GSC self-renewal and tumorigenicity.
- Low SMURF2^Thr249 phosphorylation observed in human glioblastoma.
- The SMURF2^T249A mutant mimicked SMURF2 silencing effects.
- Inactivated SMURF2^Thr249 phosphorylation increased TGFBR protein stability.
- TGFBR1 knockdown counteracted GSC phenotypes induced by the SMURF2^T249A mutant.
Conclusions:
- SMURF2^Thr249 phosphorylation is a critical regulator of GSC phenotypes.
- Targeting SMURF2^Thr249 phosphorylation offers a potential therapeutic strategy for glioblastoma.
More Related Videos
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
04:30Author Spotlight: Patient-Informed 3D Model for Studying Glioblastoma Invasion via Interstitial Fluid Flow
Published on: October 18, 2024
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...